Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/30750
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJha, Amitabh-
dc.contributor.authorDuffield, Katherine M-
dc.date.accessioned2015-03-03T11:51:50Z-
dc.date.available2015-03-03T11:51:50Z-
dc.date.issued2006-10-
dc.identifier.issn0975-0983(Online); 0376-4699(Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/30750-
dc.description2313-2320en_US
dc.description.abstract3,5-Bis(arylmethylene)-4-piperidone derivatives have emerged as novel clusters of cytotoxic agents. The focus of the current research has been to tine tune the biological activity of these compounds by rational alteration of substituents on this pharmacophore to increase potency and selectivity. These compounds arc presumed to bc devoid of gcnctoxicity and act by selective thiolation of proteins. Anticancer behavior of nine clusters of 3,5-bis(arylmethylene)-4-piperidone derivatives have been reviewed here with emphasis on their chemistry, cytoxicity and quantitative structure-activity relationship studies. en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.relation.ispartofseriesInt. Cl.8 C07Den_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJC-B Vol.45B(10) [October 2006]en_US
dc.subjectPiperidone derivativesen_US
dc.subjectAnticancer agentsen_US
dc.subjectCytotoxicen_US
dc.subjectThiolationen_US
dc.subjectTopoisomerase IIen_US
dc.subjectGreen chemistryen_US
dc.title3,5-Bis(arylmethylene)-4-piperidone derivatives as novel anticancer agentsen_US
dc.typeArticleen_US
Appears in Collections:IJC-B Vol.45B(10) [October 2006]

Files in This Item:
File Description SizeFormat 
IJCB 45B(10) 2313-2320.pdf1.87 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.